Chuankui Li, Yifan Yang, Qicai Li, Guowen Wang, Tao Tao, Lixiang Li, Haiwei Sang
{"title":"Silence of circPLK1 inhibits NSCLC progression by regulating the miR-1294/SLC16A9 axis","authors":"Chuankui Li, Yifan Yang, Qicai Li, Guowen Wang, Tao Tao, Lixiang Li, Haiwei Sang","doi":"10.1016/j.molimm.2025.11.020","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Non-small cell lung cancer (NSCLC) is the malignancy with the highest mortality worldwide. Circular RNA polo-like kinase 1 (<em>circPLK1</em>) is a circular RNA that involved in cancer progression. However, the role of <em>circPLK1</em> in NSCLC requires further investigation.</div></div><div><h3>Methods</h3><div>The expression of <em>circPLK1</em> in NSCLC cells was measured by using qRT-PCR. Bioinformatics analysis was performed to identify miRNAs that bind to <em>circPLK1</em> and the target mRNAs of these miRNAs. Cell viability, proliferation, apoptosis, migration, and invasion were assessed using CCK-8, colony formation, flow cytometry, and Transwell assays, respectively. Protein expression was evaluated by western blotting. Xenograft models were established to verify the regulatory role of circPLK1 in the miR-1294/SLC16A9 axis.</div></div><div><h3>Results</h3><div><em>circPLK1</em> was upregulaterd in NSCLC cells. Silencing <em>circPLK1</em> markedly inhibited cell viability, proliferation, migration, and invasion, while accelerating apoptosis in NSCLC cells. <em>circPLK1</em> acted as a sponge for <em>miR-1294</em> and promoted <em>SLC16A9</em> expression in NSCLC cells. Knockdown of <em>circPLK1</em> suppressed tumor growth in NSCLC by regulating the <em>miR-1294</em>/<em>SLC16A9</em> axis.</div></div><div><h3>Conclusion</h3><div><em>circPLK1</em> silence inhibited the proliferation, migration, and invasion of NSCLC cells by regulating the <em>miR-1294</em>/<em>SLC16A9</em> axis.</div></div>","PeriodicalId":18938,"journal":{"name":"Molecular immunology","volume":"189 ","pages":"Pages 216-225"},"PeriodicalIF":3.7000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular immunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0161589025002755","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Non-small cell lung cancer (NSCLC) is the malignancy with the highest mortality worldwide. Circular RNA polo-like kinase 1 (circPLK1) is a circular RNA that involved in cancer progression. However, the role of circPLK1 in NSCLC requires further investigation.
Methods
The expression of circPLK1 in NSCLC cells was measured by using qRT-PCR. Bioinformatics analysis was performed to identify miRNAs that bind to circPLK1 and the target mRNAs of these miRNAs. Cell viability, proliferation, apoptosis, migration, and invasion were assessed using CCK-8, colony formation, flow cytometry, and Transwell assays, respectively. Protein expression was evaluated by western blotting. Xenograft models were established to verify the regulatory role of circPLK1 in the miR-1294/SLC16A9 axis.
Results
circPLK1 was upregulaterd in NSCLC cells. Silencing circPLK1 markedly inhibited cell viability, proliferation, migration, and invasion, while accelerating apoptosis in NSCLC cells. circPLK1 acted as a sponge for miR-1294 and promoted SLC16A9 expression in NSCLC cells. Knockdown of circPLK1 suppressed tumor growth in NSCLC by regulating the miR-1294/SLC16A9 axis.
Conclusion
circPLK1 silence inhibited the proliferation, migration, and invasion of NSCLC cells by regulating the miR-1294/SLC16A9 axis.
期刊介绍:
Molecular Immunology publishes original articles, reviews and commentaries on all areas of immunology, with a particular focus on description of cellular, biochemical or genetic mechanisms underlying immunological phenomena. Studies on all model organisms, from invertebrates to humans, are suitable. Examples include, but are not restricted to:
Infection, autoimmunity, transplantation, immunodeficiencies, inflammation and tumor immunology
Mechanisms of induction, regulation and termination of innate and adaptive immunity
Intercellular communication, cooperation and regulation
Intracellular mechanisms of immunity (endocytosis, protein trafficking, pathogen recognition, antigen presentation, etc)
Mechanisms of action of the cells and molecules of the immune system
Structural analysis
Development of the immune system
Comparative immunology and evolution of the immune system
"Omics" studies and bioinformatics
Vaccines, biotechnology and therapeutic manipulation of the immune system (therapeutic antibodies, cytokines, cellular therapies, etc)
Technical developments.